<SEC-DOCUMENT>0001493152-21-001435-index.html : 20210120 <SEC-HEADER>0001493152-21-001435.hdr.sgml : 20210120 <ACCEPTANCE-DATETIME>20210120161509 ACCESSION NUMBER: 0001493152-21-001435 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 8 CONFORMED PERIOD OF REPORT: 20210118 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210120 DATE AS OF CHANGE: 20210120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 21538912 BUSINESS ADDRESS: STREET 1: 711 STEWART AVENUE STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 BUSINESS PHONE: (215) 345-0919 MAIL ADDRESS: STREET 1: 711 STEWART AVENUE STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>form8-k.htm <TEXT> Document 1 - file: form8-k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>ex1-1.htm <TEXT> Document 2 - file: ex1-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>ex5-1.htm <TEXT> Document 3 - file: ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>ex99-1.htm <TEXT> Document 4 - file: ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>5 <FILENAME>ex99-2.htm <TEXT> Document 5 - file: ex99-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>ex5-1_001.jpg <TEXT> Document 6 - file: ex5-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>ex99-1_001.jpg <TEXT> Document 7 - file: ex99-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>ex99-2_001.jpg <TEXT> Document 8 - file: ex99-2_001.jpg
</DOCUMENT> </SEC-DOCUMENT>